The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 708K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode.EBI
University of Strathclyde
Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLAEBI
University of Strathclyde
Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature.EBI
University of Strathclyde
Doing the methylene shuffle--further insights into the inhibition of mitotic kinesin Eg5 with S-trityl L-cysteine.EBI
University of Strathclyde
6-Acetyl-7,7-dimethyl-5,6,7,8-tetrahydropterin is an activator of nitric oxide synthases.EBI
University of Strathclyde
Synthesis and Evaluation of Small Molecule Inhibitors of the Androgen Receptor N-Terminal Domain.EBI
University of Strathclyde
M4 agonists/5HT7 antagonists with potential as antischizophrenic drugs: serominic compounds.EBI
University of Strathclyde
Structure-Based Design of a Novel Class of Autotaxin Inhibitors Based on Endogenous Allosteric Modulators.EBI
University of Strathclyde
Discovery of the first potent and selective αEBI
University of Strathclyde
Hi-JAK-ing the ubiquitin system: The design and physicochemical optimisation of JAK PROTACs.EBI
University of Strathclyde
A fragment-like approach to PYCR1 inhibition.EBI
University of Strathclyde
Optimization of Potent ATAD2 and CECR2 Bromodomain Inhibitors with an Atypical Binding Mode.EBI
University of Strathclyde
Novel tacrine analogues for potential use against Alzheimer's disease: potent and selective acetylcholinesterase inhibitors and 5-HT uptake inhibitors.EBI
University of Strathclyde
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αEBI
University of Strathclyde
Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain.EBI
University of Strathclyde
Emergence of Small-Molecule Non-RGD-Mimetic Inhibitors for RGD Integrins.EBI
University of Strathclyde
Inhibitory Kappa B Kinaseα (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers.EBI
University of Strathclyde